Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- Both men and women are eligible
- People who have a condition that mainly affects the cerebellum (a part of the brain that controls balance and coordination), such as damage caused by a stroke, a brain tumour, or a degenerative condition (whether inherited, non-inherited, or present from birth)
Who may not be able to join:
- People with a diagnosis or physical impairment that would make it difficult to complete the tasks involved or affect how results are interpreted (confirm with trial site)
- People who have a heart pacemaker or any other implanted metal device that is not safe for use in an MRI scanner
- People who have a metal fragment or foreign object in their eye or head
- People who experience severe claustrophobia (fear of enclosed spaces)
- People who experience discomfort during MRI scans, such as tattoos heating up during the scan
- People who have seizures or a history of a seizure disorder
- People who have a current alcohol or substance use disorder (based on self-report)
- People with a diagnosed history of a severe psychiatric condition such as depression or schizophrenia (based on self-report)
- People taking certain medications, specifically tricyclic antidepressants or neuroleptic (antipsychotic) medications
- People with any medical condition — including bone or joint problems, chronic pain, heart or lung conditions, or other health issues — that would make it unsafe to take part in exercise-based activities
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amy J Bastian, PhD, PT, Motion Analysis Lab in the Kennedy Krieger Institute
Phone: 443-923-2716
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Scale for the Assessment and Rating of Ataxia (SARA); Patient-Reported Outcome Measure of Ataxia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.